Shared Blood Transcriptomic Signatures between Alzheimer's Disease and Diabetes Mellitus.
Tae Sic LeeHyunju LeePublished in: Biomedicines (2021)
Alzheimer's disease (AD) and diabetes mellitus (DM) are known to have a shared molecular mechanism. We aimed to identify shared blood transcriptomic signatures between AD and DM. Blood expression datasets for each disease were combined and a co-expression network was used to construct modules consisting of genes with similar expression patterns. For each module, a gene regulatory network based on gene expression and protein-protein interactions was established to identify hub genes. We selected one module, where COPS4, PSMA6, GTF2B, GTF2F2, and SSB were identified as dysregulated transcription factors that were common between AD and DM. These five genes were also differentially co-expressed in disease-related tissues, such as the brain in AD and the pancreas in DM. Our study identified gene modules that were dysregulated in both AD and DM blood samples, which may contribute to reveal common pathophysiology between two diseases.
Keyphrases
- genome wide
- gene expression
- poor prognosis
- genome wide identification
- dna methylation
- glycemic control
- transcription factor
- network analysis
- bioinformatics analysis
- rna seq
- type diabetes
- cognitive decline
- metabolic syndrome
- binding protein
- computed tomography
- multiple sclerosis
- long non coding rna
- pet ct
- mild cognitive impairment
- skeletal muscle
- white matter
- functional connectivity